The purpose of this study is to evaluate the efficacy and safety of a new stimulation treatment delivered by a device called BrainQ. This device is designed to improve activities of daily living and quality of life in people with SCI by delivering low levels of an electrical field, non-invasively through the skull to stimulate nerves that control muscles in a weakened upper limb. The study will assess the effect BrainQ stimulation has on strength, movement, spasticity, and pain in the wrist/hand and upper extremities, ability to use upper extremities in activities of daily, and quality of life.
Participation can last up to 34 weeks.
- Individuals diagnosed 12-30 months ago with traumatic or incident-related non-traumatic (e.g. arthritis, cancer, inflammation infections, or disc degeneration of the spine) chronic cervical incomplete SCI (AIS B-D)
- aged 18-75 years
- have significant upper limb weakness on at least one side as determined by an evaluation by study staff
- have shoulder function sufficient to perform study tasks as determined by study staff
- are medically stable and have a medication treatment plan without any planned major modifications.
Participants who complete the full 34 weeks of the study will receive $500.